Nanosonics and 1 more ASX healthcare share to buy and hold beyond 2025

Here we look at 2 ASX healthcare shares to potentially buy and hold beyond 2025: ResMed Inc (ASX: RMD) and Nanosonics Ltd. (ASX: NAN).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Of all the industry sectors represented on the ASX, the ASX healthcare sector is definitely one of my favourites. Our ageing population is driving an ever-increasing demand for healthcare services. Also, continual technology advances in this market segment is driving demand higher.

In this article we examine 2 of my top ASX healthcare shares right now: ResMed Inc (ASX: RMD) and Nanosonics Ltd. (ASX: NAN). I am attracted to both of them because of their high level of technological innovation, entrenched market positions, and growing international exposure.

I believe both have strong long-term growth potential, which is likely to translate to above average shareholder returns over the next 5 years.

Nanosonics

ASX healthcare company Nanosonics manufactures and distributes disinfection system for ultrasound probes. Nanosonic's core product, the trophon EPR disinfection system, has achieved an industry reputation as the leader in its market niche.

Nanosonics has seen strong revenue growth over the past 5 years. In particular, the company has continued to see solid revenue growth in its largest market, the US. It also has been experiencing strong growth across Asia, Europe and the Middle East. Nanosonics achieved total revenue of $48.5 million for the first half of FY20. This was an increase of 19% on the prior corresponding period (pcp).

In its most recent market update, the company revealed that sales momentum has continued during the early phase of the coronavirus pandemic. Unaudited sales for the third quarter of FY20 were significantly higher than the prior corresponding period. However, lower than anticipated overall growth of its installed base is predicted for Q4, due to difficulty accessing some hospitals.

Despite any short-term challenges, I believe that Nanosonics is well placed to grow strongly over the next 5 years, on the back of the growing global trend towards stricter disinfection control in hospitals.

ResMed

Another ASX healthcare share that I would consider adding to your share portfolio is ResMed. The company designs and manufactures healthcare devices and cloud-based software solutions for sleep apnea and other respiratory conditions.

Revenue growth over the past few years has been assisted by new product launches and successful targeted acquisitions. ResMed's global scale and entrenched market position provide it with a strong competitive advantage. ResMed recorded a super strong 47% increase in net income during the third quarter of FY20.

I believe that the demand for ResMed's products will continue over the next decade. Research from ResMed estimates that around 1 billion people globally are impacted by sleep apnoea worldwide. In addition, more than 80% of cases are estimated to be undiagnosed globally.

Phil Harpur owns shares of Nanosonics Limited and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Nanosonics Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »